[{"indications": "Indications\u00a0see notes above; also inappropriate secretion of antidiuretic hormone, %s\n(From Antidiuretic hormone antagonists: British National Formulary)\nAntidiuretic hormone antagonists", "name": "DEMECLOCYCLINE HYDROCHLORIDE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.3 Tetracyclines", "DEMECLOCYCLINE HYDROCHLORIDE"], "cautions": "Cautions\u00a0\n(From 5.1.3 Tetracyclines: British National Formulary)\nCautions\u00a0Tetracyclines may increase muscle weakness in patients with myasthenia gravis, and exacerbate systemic lupus erythematosus. Antacids, and aluminium, calcium, iron, magnesium and zinc salts decrease the absorption of tetracyclines; milk also reduces the absorption of demeclocycline, oxytetracycline, and tetracycline. Other interactions: Appendix 1 (tetracyclines)., but photosensitivity\r\nmore common (avoid exposure to sunlight or sun lamps)", "side-effects": "Side-effects\u00a0\n(From 5.1.3 Tetracyclines: British National Formulary)\nSide-effects\u00a0Side-effects of the tetracyclines include nausea, vomiting, diarrhoea (antibiotic-associated colitis reported occasionally), dysphagia, and oesophageal irritation. Other rare side-effects include hepatotoxicity, pancreatitis, blood disorders, photosensitivity (particularly with demeclocycline), and hypersensitivity reactions (including rash, exfoliative dermatitis, Stevens-Johnson syndrome, urticaria, angioedema, anaphylaxis, pericarditis). Headache and visual disturbances may indicate benign intracranial hypertension (discontinue treatment); bulging fontanelles have been reported in infants. ; also\r\nreversible nephrogenic diabetes insipidus, acute renal failure", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/215537.htm", "doses": ["150\u00a0mg every 6 hours or 300\u00a0mg every\r\n12 hours"], "pregnancy": "Pregnancy\u00a0\n(From 5.1.3 Tetracyclines: British National Formulary)\nPregnancy\u00a0Tetracyclines should not be given to pregnant women. Effects on skeletal development have been documented when tetracyclines have been used in the first trimester in animal studies. Administration during the second or third trimester may cause discoloration of the child\u2019s teeth, and maternal hepatotoxicity has been reported with large parenteral doses."}]